Caricamento...
Singling out FLI1 in Paris-Trousseau syndrome
In this issue of Blood, using induced pluripotent stem cell (iPSC)–derived human megakaryocytes (iMegs), Vo et al find that the megakaryocyte/platelet defects observed in patients with Paris-Trousseau syndrome (PTS) are due solely to hemizygous deletion of the transcription factor (TF) FLI1.(1)
Salvato in:
| Pubblicato in: | Blood |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society of Hematology
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5492094/ https://ncbi.nlm.nih.gov/pubmed/28663223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-05-781252 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|